ABCM/N fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ABCM/N does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company